Trial · NCT00669396
Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
NCT00669396, Not applicable, Completed, University of Utah; results first posted 2009-08-06
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception. Trials, record NCT00669396. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00669396
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
- NCT number
- NCT00669396
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 57 participants, actual
- Lead sponsor
- University of Utah
- Conditions
- Pregnancy
- Interventions
- Copper T380 IUD, levonorgestrel
- First posted
- 2008-04-30
- Last updated
- 2014-12-22
- Results first posted
- 2009-08-06
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception | 6 months | Use of a method of contraception with a typical efficacy rate \>= to 92%. This includes combined hormonal contraception (combined oral contraceptive pills, the contraceptive patch and ring), sterilization, IUDs, Depo-provera, and contraceptive implants. |
| Secondary | Pregnancy | 6 months | positive urine pregnancy test at anytime within 6 months of presenting for emergency contraception. |
| Secondary | Infection | 6 months | diagnosis and treatment for pelvic inflammatory disease |
| Secondary | IUD Expulsion, Removal, or Perforation | 6 months | patient reports IUD expulsion, removal, or perforation OR one of these events was documented at the clinic where patient received care. |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception | 6 months | participants | NUMBER | |
| SECONDARY | Pregnancy | 6 months | participants | NUMBER | |
| SECONDARY | Infection | 6 months | participants | NUMBER | |
| SECONDARY | IUD Expulsion, Removal, or Perforation | 6 months | participants | NUMBER |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception | Copper T380 IUD | 9 | participants | ||
| Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception | Levonorgestrel | 13 | participants | ||
| Pregnancy | Copper T380 IUD | 0 | participants | ||
| Pregnancy | Levonorgestrel | 2 | participants | ||
| Infection | Copper T380 IUD | 0 | participants | ||
| Infection | Levonorgestrel | 0 | participants | ||
| IUD Expulsion, Removal, or Perforation | Copper T380 IUD | 5 | participants | ||
| IUD Expulsion, Removal, or Perforation | Levonorgestrel | 0 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Copper T380 IUD | 23 | |
| Overall Study | STARTED | Levonorgestrel | 34 | |
| Overall Study | COMPLETED | Copper T380 IUD | 13 | |
| Overall Study | COMPLETED | Levonorgestrel | 22 | |
| Overall Study | NOT COMPLETED | Copper T380 IUD | 10 | |
| Overall Study | NOT COMPLETED | Levonorgestrel | 12 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Copper T380 IUD | ||
| Total, all-cause mortality | Levonorgestrel | ||
| Total, other adverse events | Copper T380 IUD | 0 | 23 |
| Total, other adverse events | Levonorgestrel | 0 | 34 |
| Total, serious adverse events | Copper T380 IUD | 0 | 23 |
| Total, serious adverse events | Levonorgestrel | 0 | 34 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons5
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Copper T380 IUD vs Levonorgestrel: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception | Trial comparisons |
| Copper T380 IUD vs Levonorgestrel: Infection | Trial comparisons |
| Copper T380 IUD vs Levonorgestrel: Pregnancy | Trial comparisons |
| Copper T380 IUD vs Levonorgestrel: IUD Expulsion, Removal, or Perforation | Trial comparisons |
| Copper T380 IUD vs Levonorgestrel: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00669396
GET https://conductscience.org/api/trials/v1/NCT00669396/registered